Dr. Eduardo Sanchez serves as Chief Medical Officer (CMO) for Prevention for the American Heart Association (AHA). He is the Principal Investigator of the National Hypertension Control Initiative, a cooperative agreement with the U.S. Department of Health and Human Services Office of Minority Health and the Health Resources and Services Administration. He is the AHA clinical lead on Target: BP (a joint blood pressure control initiative with the American Medical Association) and KnowDiabetesbyHeartTM (a joint cardiovascular risk factor control initiative with the American Diabetes Association). Dr. Sanchez is one of the authors of the AHA Presidential Advisory on Structural Racism and its health effects.
Prior to joining AHA, Dr. Sanchez served as Vice President and CMO for Blue Cross and Blue Shield of Texas. He also served as Commissioner of the Texas Department of State Health Services from 2004 to 2006 and Commissioner of the Texas Department of Health from 2001 to 2004. Dr. Sanchez serves on numerous boards and advisory committees at the local, state, and national levels and is a Fellow of the American Heart Association.
Dr. Sanchez obtained his MD from the University of Texas Southwestern Medical School in Dallas, an MPH from the UT Health Science Center at Houston School of Public Health, and an MS in biomedical engineering from Duke University. He holds a BS in biomedical engineering and a BA in chemistry from Boston University. Dr. Sanchez is a Fellow of the American Heart Association.